- Home
- CLRB vs SSM Comparison
CLRB vs SSM Comparison
Compare CLRB & SSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLRB | SSM |
|---|---|---|
| Founded | 2002 | 2016 |
| Country | United States | Germany |
| Employees | N/A | 43 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1M | 10.6M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLRB | SSM |
|---|---|---|
| Price | $2.83 | $6.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 24.4K | 2.0K |
| Earning Date | 05-12-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1,462,987.20 |
| Revenue Next Year | N/A | $48.49 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.23 | $5.34 |
| 52 Week High | $10.19 | $10.47 |
Technical Indicators
Market Signals| Indicator | CLRB | SSM |
|---|---|---|
| Relative Strength Index (RSI) | 42.08 | 50.03 |
| Support Level | $2.45 | $5.92 |
| Resistance Level | $3.44 | $7.30 |
| Average True Range (ATR) | 0.17 | 0.32 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 13.95 | 62.08 |
Price Performance
Historical ComparisonAbout CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About SSM Sono Group N.V. Ordinary Shares
Sono Group NV is engaged in the field of solar-powered electric mobility. With its proprietary solar technology, the company is able to integrate solar panels into a vehicle's bodywork, using energy captured from the sun to charge the vehicle's battery. The group is engaged in the design and development of its own first solar electric vehicle, the Sion. Its Products and Services includes Complete Solar Solutions, Solar Charge Controllers, Solar Modules, and Data Services and Engineering Services.